Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

NCT06434896 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06434896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06434896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Recruiting
Start date
March 5, 2020
Completion date
December 31, 2026
Enrollment
1,320 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, colon cancer stage ii, recurrence